2022 MIPS Performance Feedback
The Advocacy Council strongly encourages you to view this information as soon as possible for two reasons.
EFT fees burden physician offices
For years, physicians have faced reduced payments from commercial health plans using virtual credit cards and third-party electronic payment vendors for standa…
CMS publishes list of products subject to Medicare price negotiation
The Inflation Reduction Act of 2022 (IRA) had many provisions only indirectly related to inflation, including important changes to Medicare.
2024 MIPS Proposed Changes
This article provides a summary of key proposals and changes to the traditional MIPS program that will impact allergists.
AMA’s Vital Physician Practice Expense Study will collect data on physician practice expenses
A new national AMA study, supported by the College and 173 health care organizations, to collect data on physician practice expenses.
ACAAI House of Delegates continues its work
The College’s House of Delegates’ (HOD) goal is to build a communications network between the HOD and state and regional societies.
Update on EMK legislation
Congress must pass legislation to reauthorize the FAA before current authorization expires on Oct. 1, 2023.
College supports smoke and heat emergency bills
These bills would help federal, state, and local governments better understand, manage, and communicate on air quality issues caused by excessive heat and wild…
2023 diagnosis coding specificity
Since this rule was implemented, we have received very few reports of audits denying claims using unspecified codes - until recently
2023 Q2 Advocacy Update
The Advocacy Council continues its work on important issues that affect the allergy specialty, allergy practices and allergists.
2023 – Advocacy Council Executive Director of Advocacy and Government Affairs
J. Allen Meadows, MD, FACAAI, has been appointed to the position of Executive Director of Advocacy and Government Affairs.
New JZ modifier implementation begins July 1
Medicare will require the use of the new JZ modifier for single-dose containers when there are no discarded amounts of a drug/biologic.
Medical Debt Collection
Good faith estimates and medical debt collection will likely impact your practice and your patients in 2023.
Subspecialty Loan Repayment Program
In FY 2024, the American Academy of Pediatrics, the College and other medical specialty societies support the request of $30 million for PSLRP.
How will the debt ceiling affect your practice?
After weeks of negotiations, President Biden and House Speaker Kevin McCarthy (R-CA) reached an agreement over Memorial Day weekend on a framework for raising …
CIGNA’s Modifier -25 Policy Delayed
This new policy would markedly increase allergists’ offices administrative burden and restrict the use of modifier 25 on E&M services.
Confirming diagnoses
The Advocacy Council regularly receives queries from members on how to correctly code. Many are common issues, including for coding unconfirmed diagnoses.
Medical Liability Insurance Increases
The AMA noted medical liability premiums between 2019 and 2022 have increased at a rate that hasn’t been observed in more than two decades.
2023 MA Final Rule
The Final Rule clarifies requirements regarding coverage criteria for basic benefits, including allergy services.
Expiration of COVID HIPAA Enforcement Discretion
To help providers come into compliance with the HIPAA Rules on telehealth, OCR is providing a 90-day transition period ending August 9, 2023.
